Pricing Log in Create free account
Friday 6 November 2026 Export SNN’s income statement to Excel — free account

Smith & Nephew SNATS, Inc.

SNN Healthcare Medical Devices

Smith & Nephew SNATS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, up 6.09% from fiscal 2024.

31.12 0.89 −2.78%
Market cap
$13.4B
P/E
38.9×
Fwd P/E
18.9×
Dividend yield
2.49%
F-score
7/9
Altman Z
3.49
Beneish M
−2.70
Dividend safety
61/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Smith & Nephew SNATS, Inc. (SNN) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Smith & Nephew SNATS, Inc. (SNN) trades at a P/S ratio of 1.4×. Over the past ten years it has ranged from 0.9× (October 2023) to 3.8× (April 2018); the current reading is higher than 30% of that period. That is below the Medical Devices industry median of 2.5× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 1.4× 33.48%
FY2024 1.1× (8.45%)
FY2023 1.1× (3.57%)
FY2022 1.2× (24.66%)
FY2021 1.6× (17.78%)
FY2020 1.9× (20.82%)
FY2019 2.4× (13.50%)
FY2018 2.8× (17.31%)
FY2017 3.4× 16.37%
FY2016 2.9× (15.76%)

Quarterly newest first

Period P/S ratio Change
Jun 2023 1.3× 15.84%
Dec 2022 1.2× (3.24%)
Jun 2022 1.2× (22.85%)
Dec 2021 1.5× (18.65%)
6 more quarters

Against its own ten years

Low 0.9× High 3.8×
Ten-year median 1.9×
Current reading's percentile 33

P/S ratio against peers

Company P/S ratio
SNN Smith & Nephew SNATS, Inc. 1.4×
BRKR Bruker Corporation compare 2.5×
PODD Insulet Corporation compare 3.4×
GMED Globus Medical, Inc. compare 3.5×
BIO Bio-Rad Laboratories, Inc. compare 3.8×
BIO.B Bio-Rad Laboratories, Inc. compare 3.9×
PEN Penumbra, Inc. compare 8.1×
TXG 10x Genomics compare 12.4×
GKOS Glaukos Corporation compare 18.8×
Medical Devices industry median 2.5×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on SNN